- Other Products
- CCP
COMPREHENSIVE IMMUNOGENICITY ANALYSIS OF AAV THERAPIES:
Celik S, Kulak K, Kozma V, Klint C, Vallette B, Nilsson C, Lallemand C, Tovey M, Bovin L F, Butler S, Schwenkert M, Rodo J
Learn more about how combining immuno- and cell-based methodologies, effectively addresses the crucial demand in the clinical development of AAV-mediated gene therapies by providing precise assessments of NAbs and TAbs.
ELUCIDATING COMPLEMENT ACTIVATION MECHANISMS IN AAV GENE THERAPY:
Kulak K, Kozma V, Klint C, Nilsson C , Butler S, Schwenkert M, Rodo J
Gain deeper insights into the predictive assessment of AAV-mediated immunogenicity and how understanding and evaluating patient responses to AAV-mediated gene therapy comprehensively is crucial.
